Evolution in the Presentation, Treatment, and Outcomes of Patients with Acute Mesenteric Ischemia

医学 病因学 血运重建 肠系膜缺血 内科学 外科 心房颤动 队列 血栓形成 心脏病学 缺血 心肌梗塞
作者
Elizabeth L. Chou,Linda J. Wang,Rachel M. McLellan,Zach M. Feldman,Christopher A. Latz,Glenn M. LaMuraglia,W. Darrin Clouse,Matthew J. Eagleton,Mark F. Conrad
出处
期刊:Annals of Vascular Surgery [Elsevier BV]
卷期号:74: 53-62 被引量:28
标识
DOI:10.1016/j.avsg.2021.01.116
摘要

•Acute mesenteric ischemia continues to confer high rate of mortality and morbidity. •Etiology of acute mesenteric ischemia affects outcomes, with the incidence of embolic etiology decreasing over time. •There is a survival benefit to timely revascularization. Objectives Acute mesenteric ischemia (AMI) is a life-threatening condition associated with dismal outcomes. This study sought to evaluate the evolution of presentation, treatment, and outcomes of AMI over the past two decades. Methods AMI patients presenting at a single institution were reviewed (1993–2016). Venous thrombosis patients were excluded. Primary outcome was 30-day mortality. Patients were stratified by etiology and diagnosis date (before 2004 versus 2004 and later). Ordered logistic regression was performed for longitudinal temporal analysis. Results 303 patients were identified. AMI mechanisms included: embolic (49%), thrombotic (29%), and non-occlusive (NOMI) (22%). The majority were women (55%), 50% had atrial fibrillation, and 23% were on anticoagulation (AC) therapy. Mean age was 72±13 years. 345 procedures were performed in 242 patients: 321 open and 24 hybrid/endovascular. Among the 189 embolic/thrombotic patients who were managed operatively, 45% (n=85) underwent mesenteric revascularization while 39 (21%) had findings of non-survivable bowel necrosis (NSBN). Among the 104 patients who did not undergo revascularization, 64 (62%) died within 30-days compared to 36 out of 85 (42%) patients who were revascularized (P=0.01). 30-day mortality was 61% and stable over time (P=0.91); when stratified by AMI etiology, the thrombotic cohort had worse survival than embolic and NOMI patients (P=0.04). Since 2000, there was a significant decrease in the percentage of embolic AMI events (P=0.04). The percentage of patients who underwent operative management decreased also over time (P=0.01, 81% → 61%), which was correlated with an increasing number of patients being made comfort measures only (CMO) prior to surgical intervention (50% → 70%, P=0.02). The majority of patients (55%) were ultimately made CMO during their hospitalization. Predictors of 30-day mortality included a preoperative white blood cell count (WBC) ≥ 25 K/ µL. (OR 3.0, P=0.002) and lactate ≥ 2.3 mmol/L (OR 2.8, P=0.045). NSBN predictors included WBC ≥ 24 K/ µL. (OR 3.4 P=0.03) and lactate ≥ 3.8 mmol/L (OR 3.6, P=0.04). Conclusions Despite advances in critical care over the past 25 years, AMI continues to be associated with poor prognosis. The survival benefit observed in patients who undergo revascularization supports an aggressive approach towards early vascular intervention, although this requires further study. The importance of early diagnosis, prognostication and advanced directives is highlighted given the high morbidity, mortality and use of comfort measures associated with AMI. Acute mesenteric ischemia (AMI) is a life-threatening condition associated with dismal outcomes. This study sought to evaluate the evolution of presentation, treatment, and outcomes of AMI over the past two decades. AMI patients presenting at a single institution were reviewed (1993–2016). Venous thrombosis patients were excluded. Primary outcome was 30-day mortality. Patients were stratified by etiology and diagnosis date (before 2004 versus 2004 and later). Ordered logistic regression was performed for longitudinal temporal analysis. 303 patients were identified. AMI mechanisms included: embolic (49%), thrombotic (29%), and non-occlusive (NOMI) (22%). The majority were women (55%), 50% had atrial fibrillation, and 23% were on anticoagulation (AC) therapy. Mean age was 72±13 years. 345 procedures were performed in 242 patients: 321 open and 24 hybrid/endovascular. Among the 189 embolic/thrombotic patients who were managed operatively, 45% (n=85) underwent mesenteric revascularization while 39 (21%) had findings of non-survivable bowel necrosis (NSBN). Among the 104 patients who did not undergo revascularization, 64 (62%) died within 30-days compared to 36 out of 85 (42%) patients who were revascularized (P=0.01). 30-day mortality was 61% and stable over time (P=0.91); when stratified by AMI etiology, the thrombotic cohort had worse survival than embolic and NOMI patients (P=0.04). Since 2000, there was a significant decrease in the percentage of embolic AMI events (P=0.04). The percentage of patients who underwent operative management decreased also over time (P=0.01, 81% → 61%), which was correlated with an increasing number of patients being made comfort measures only (CMO) prior to surgical intervention (50% → 70%, P=0.02). The majority of patients (55%) were ultimately made CMO during their hospitalization. Predictors of 30-day mortality included a preoperative white blood cell count (WBC) ≥ 25 K/ µL. (OR 3.0, P=0.002) and lactate ≥ 2.3 mmol/L (OR 2.8, P=0.045). NSBN predictors included WBC ≥ 24 K/ µL. (OR 3.4 P=0.03) and lactate ≥ 3.8 mmol/L (OR 3.6, P=0.04). Despite advances in critical care over the past 25 years, AMI continues to be associated with poor prognosis. The survival benefit observed in patients who undergo revascularization supports an aggressive approach towards early vascular intervention, although this requires further study. The importance of early diagnosis, prognostication and advanced directives is highlighted given the high morbidity, mortality and use of comfort measures associated with AMI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
redking发布了新的文献求助10
刚刚
缥缈剑愁发布了新的文献求助10
1秒前
CodeCraft应助圆蓬蓬采纳,获得10
1秒前
zhaoyuli完成签到,获得积分10
1秒前
啊啊发布了新的文献求助10
1秒前
1秒前
ZH发布了新的文献求助10
3秒前
研友_VZG7GZ应助Endeavor采纳,获得10
3秒前
warden完成签到 ,获得积分10
3秒前
科研通AI2S应助sisyphus_yy采纳,获得10
4秒前
施天问发布了新的文献求助10
4秒前
6秒前
Singularity应助内向寒云采纳,获得10
6秒前
dd完成签到 ,获得积分10
6秒前
7秒前
Miracle发布了新的文献求助10
8秒前
开花完成签到,获得积分10
8秒前
量子星尘发布了新的文献求助10
9秒前
10秒前
redking完成签到,获得积分10
10秒前
lingquanmeng完成签到,获得积分10
11秒前
11秒前
羽生发布了新的文献求助10
11秒前
隐形曼青应助miumiu采纳,获得10
12秒前
beckham发布了新的文献求助10
13秒前
施天问完成签到,获得积分10
14秒前
uu发布了新的文献求助10
14秒前
15秒前
15秒前
15秒前
小蘑菇应助Miracle采纳,获得10
15秒前
轩轩轩轩完成签到 ,获得积分10
16秒前
16秒前
17秒前
litao完成签到,获得积分10
18秒前
乐乐应助九千七采纳,获得10
20秒前
梁三柏应助makabaka采纳,获得10
20秒前
21秒前
21秒前
xyz发布了新的文献求助10
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975755
求助须知:如何正确求助?哪些是违规求助? 3520108
关于积分的说明 11200829
捐赠科研通 3256492
什么是DOI,文献DOI怎么找? 1798298
邀请新用户注册赠送积分活动 877509
科研通“疑难数据库(出版商)”最低求助积分说明 806403